Document is current
Any future updates will be listed below
-
Authors
Askari, Mohammad Ali
Vajdi, Mahdi https://orcid.org/0000-0002-2828-1161
Khorvash, Fariborz
Yegdaneh, Afsaneh
-
Funding
Funding for this research was provided by:
Isfahan University of Medical Sciences (140389)
- License Information
-
More Information
Article History
Received: 5 August 2025
Accepted: 18 September 2025
First Online: 23 October 2025
Declarations
:
: The study protocol is drafted in accordance with the SPIRIT checklist and is approved by the Medical Ethics Committee of IUMS, Isfahan, Iran (ID: IR.MUI.MED.REC.1403.231). The current trial is registered at the Iranian Registry of Clinical (ID: IRCT20241009063312N1). This trial will be conducted in accordance with the principles outlined in the Declaration of Helsinki. During the initial visit, each participant will be fully informed about the potential risks and benefits of the study. We will emphasize the confidentiality of their personal information, address any questions they may have, and assure them that general study finding will be shared with them upon completion. The final results will also be published for the benefit of the broader research community, without disclosing any names or personal identifiers. Written informed consent will be obtained from all participants prior to enrollment. Importantly, this intervention will not interfere with the routine treatment of patients with migraine.
: This paper does not contain any personal data.
: The authors declare that they have no competing interests.
